214 related articles for article (PubMed ID: 34404600)
1. Open irreversible electroporation for isolated local recurrence of pancreatic ductal adenocarcinoma after primary surgery.
Heger U; Mack C; Tjaden C; Pan F; Pausch T; Hinz U; Sommer CM; Hackert T
Pancreatology; 2021 Oct; 21(7):1349-1355. PubMed ID: 34404600
[TBL] [Abstract][Full Text] [Related]
2. Irreversible electroporation as treatment of locally advanced and as margin accentuation in borderline resectable pancreatic adenocarcinoma.
Marsanic P; Mellano A; Sottile A; De Simone M
Med Biol Eng Comput; 2017 Jul; 55(7):1123-1127. PubMed ID: 28078482
[TBL] [Abstract][Full Text] [Related]
3. Treatment of locally advanced pancreatic cancer with irreversible electroporation - a Danish single center study of safety and feasibility.
Flak RV; Stender MT; Jensen TM; Andersen KL; Henriksen SD; Mortensen PB; Sall M; Thorlacius-Ussing O
Scand J Gastroenterol; 2019 Feb; 54(2):252-258. PubMed ID: 30907286
[TBL] [Abstract][Full Text] [Related]
4. Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy.
Martin RC; Kwon D; Chalikonda S; Sellers M; Kotz E; Scoggins C; McMasters KM; Watkins K
Ann Surg; 2015 Sep; 262(3):486-94; discussion 492-4. PubMed ID: 26258317
[TBL] [Abstract][Full Text] [Related]
5. Irreversible Electroporation for Locally Advanced Pancreatic Cancer.
Timmer FEF; Geboers B; Ruarus AH; Schouten EAC; Nieuwenhuizen S; Puijk RS; de Vries JJJ; Meijerink MR; Scheffer HJ
Tech Vasc Interv Radiol; 2020 Jun; 23(2):100675. PubMed ID: 32591191
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous Image-Guided Irreversible Electroporation for the Treatment of Unresectable, Locally Advanced Pancreatic Adenocarcinoma.
Narayanan G; Hosein PJ; Beulaygue IC; Froud T; Scheffer HJ; Venkat SR; Echenique AM; Hevert EC; Livingstone AS; Rocha-Lima CM; Merchan JR; Levi JU; Yrizarry JM; Lencioni R
J Vasc Interv Radiol; 2017 Mar; 28(3):342-348. PubMed ID: 27993507
[TBL] [Abstract][Full Text] [Related]
7. Irreversible electroporation to bring initially unresectable locally advanced pancreatic adenocarcinoma to surgery: the IRECAP phase II study.
Tasu JP; Herpe G; Damion J; Richer JP; Debeane B; Vionnet M; Rouleau L; Carretier M; Ferru A; Ingrand P; Tougeron D
Eur Radiol; 2024 Mar; ():. PubMed ID: 38494526
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factor analysis of irreversible electroporation for locally advanced pancreatic cancer - A multi-institutional clinical study in Asia.
Yang PC; Huang KW; Pua U; Kim MD; Li SP; Li XY; Liang PC
Eur J Surg Oncol; 2020 May; 46(5):811-817. PubMed ID: 31839436
[TBL] [Abstract][Full Text] [Related]
9. Multimodal therapy with or without irreversible electroporation for unresectable locally advanced pancreatic adenocarcinoma: a systematic review and meta-analysis.
Sugumar K; Hurtado A; Naik I; Hue JJ; Rothermel LD; Ammori JB; Hardacre JM; Winter JM; Ocuin LM
HPB (Oxford); 2022 May; 24(5):586-595. PubMed ID: 35000842
[TBL] [Abstract][Full Text] [Related]
10. Systematic Review of Surgical and Percutaneous Irreversible Electroporation in the Treatment of Locally Advanced Pancreatic Cancer.
Moris D; Machairas N; Tsilimigras DI; Prodromidou A; Ejaz A; Weiss M; Hasemaki N; Felekouras E; Pawlik TM
Ann Surg Oncol; 2019 Jun; 26(6):1657-1668. PubMed ID: 30843163
[TBL] [Abstract][Full Text] [Related]
11. Irreversible Electroporation for Nonthermal Tumor Ablation in Patients with Locally Advanced Pancreatic Cancer: Initial Clinical Experience in Japan.
Sugimoto K; Moriyasu F; Tsuchiya T; Nagakawa Y; Hosokawa Y; Saito K; Tsuchida A; Itoi T
Intern Med; 2018 Nov; 57(22):3225-3231. PubMed ID: 29984761
[TBL] [Abstract][Full Text] [Related]
12. The efficacy and safety of the open approach irreversible electroporation in the treatment of pancreatic cancer: A systematic review.
Charalambous P; Moris D; Karachaliou GS; Papalampros A; Dimitrokallis N; Tsilimigras DI; Oikonomou D; Petrou A
Eur J Surg Oncol; 2020 Sep; 46(9):1565-1572. PubMed ID: 32536525
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous irreversible electroporation with systemic treatment for locally advanced pancreatic adenocarcinoma.
Leen E; Picard J; Stebbing J; Abel M; Dhillon T; Wasan H
J Gastrointest Oncol; 2018 Apr; 9(2):275-281. PubMed ID: 29755766
[TBL] [Abstract][Full Text] [Related]
14. Comparison of combination therapies in the management of locally advanced pancreatic cancer: Induction chemotherapy followed by irreversible electroporation vs radiofrequency ablation.
He C; Wang J; Zhang Y; Cai Z; Lin X; Li S
Cancer Med; 2020 Jul; 9(13):4699-4710. PubMed ID: 32410380
[TBL] [Abstract][Full Text] [Related]
15. A prospective, multi-institution assessment of irreversible electroporation for treatment of locally advanced pancreatic adenocarcinoma: initial outcomes from the AHPBA pancreatic registry.
Holland MM; Bhutiani N; Kruse EJ; Weiss MJ; Christein JD; White RR; Huang KW; Martin RCG
HPB (Oxford); 2019 Aug; 21(8):1024-1031. PubMed ID: 30737097
[TBL] [Abstract][Full Text] [Related]
16. Irreversible electroporation in locally advanced pancreatic cancer.
Polyakov AN; Patyutko YI; Kudashkin NE; Kantieva DM; Romanova KA; Nasonova EA; Korshak AV; Egenov OA; Podluzhnyi DV
Khirurgiia (Mosk); 2023; (10):29-38. PubMed ID: 37916555
[TBL] [Abstract][Full Text] [Related]
17. Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma.
Martin RC; McFarland K; Ellis S; Velanovich V
J Am Coll Surg; 2012 Sep; 215(3):361-9. PubMed ID: 22726894
[TBL] [Abstract][Full Text] [Related]
18. Irreversible Electroporation in pancreatic ductal adenocarcinoma: Is there a role in conjunction with conventional treatment?
de Liguori Carino N; O'Reilly DA; Siriwardena AK; Valle JW; Radhakrishna G; Pihlak R; McNamara MG
Eur J Surg Oncol; 2018 Oct; 44(10):1486-1493. PubMed ID: 30146253
[TBL] [Abstract][Full Text] [Related]
19. [Combining intraoperative ultrasound-guided irreversible electroporation with chemotherapy for treating locally advanced pancreatic cancer: a clinical report of 64 cases].
Li SP; He CB; Wang J; Mao YZ; Lao XM; Cui BK; Lin XJ
Zhonghua Wai Ke Za Zhi; 2020 Oct; 58(10):787-792. PubMed ID: 32993267
[No Abstract] [Full Text] [Related]
20. Multicenter randomized controlled trial and registry study to assess the safety and efficacy of the NanoKnife® system for the ablation of stage 3 pancreatic adenocarcinoma: overview of study protocols.
Narayanan G; Bilimoria MM; Hosein PJ; Su Z; Mortimer KM; Martin RCG
BMC Cancer; 2021 Jul; 21(1):785. PubMed ID: 34233640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
